CN1202358A - Medicinal liquid and ointment for curing ache folliculitis and eczema - Google Patents
Medicinal liquid and ointment for curing ache folliculitis and eczema Download PDFInfo
- Publication number
- CN1202358A CN1202358A CN 97111378 CN97111378A CN1202358A CN 1202358 A CN1202358 A CN 1202358A CN 97111378 CN97111378 CN 97111378 CN 97111378 A CN97111378 A CN 97111378A CN 1202358 A CN1202358 A CN 1202358A
- Authority
- CN
- China
- Prior art keywords
- unguentum
- medicine
- folliculitis
- water preparation
- ointment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The medicinal liquid and the ointment are used together, and their main components include antiseptic, Ribavirin, hydrocortisone, dexamethasone, methacycline and metronidzole, which are compounded together with alcohol and medical vaseline into the medicinal liquid and the ointment. Clinical application shows that the present invention has obvious curative effect and when introduced via ultrasonic wave they can result in ever high curative effect.
Description
The present invention relates to a kind of water preparation and unguentum for the treatment of acne, folliculitis, eczema.
Acne was mainly in man, young woman's face in the past, and observe the man of the right side of fifty, women face in recent years also has acne to take place more.This is because the serious pollution of (1) air.(2) Xi Ni cosmetics (hide frost) have stopped up the discharge that pore has influenced sebum, Propiobacterium breeds very fast in the nutritious environment of ferrum oxygen, destroy follicular wall and entered corium, make skin of face red and swollen, pimple occur, extrude with hands and to cause skin of face to infect, finally make face color class, cicatrix occur.(3) divide the disorder of oozing in, the women is apparent in view in menstrual period.So far, hospital does not have the Therapeutic Method of system to this type of disease, and curative effect is not obvious.
A kind of water preparation, the unguentum for the treatment of acne, folliculitis, eczema that provides at having the deficiency that exists in the therapeutic process now is provided, this medicine Clinical Practice, cost is low, has no side effect, and compound method is easy, and is evident in efficacy.
The medicine of water preparation of the present invention, unguentum is composed as follows:
1, water preparation (weight 500ml)
Chloramphenicol inj: 1～2g
Three nitrogen are eaten nucleoside injection: 400～800mg
Hydrocortisone injection: 40～80mg
2, unguentum (weight 80g)
Antibiotics: 1.2～10g
Dexamethasone tablet: 15～20mg
Metronidazole: 3～4g
The preparation of water preparation is said medicine to be added 75% ethanol 300ml, adding distil water 100ml, and mix homogeneously is the transparent whites water preparation in measuring cup.
The preparation of unguentum is medicine to be added mortar be ground into fine-powdered, mixes well with the 50g medical ventolin to be unguentum.
Antibiotics recited above is penicillin (powder for injection) 4～6g (6,680,000～13,366 ten thousand unit), cephalosporin (powder for injection) 2.5～3.5g, streptomycin 2～3g, erythromycin (powder for injection) 1.2～1.8g, sulfanilamide (SMZ) 6～10g selects wherein one or both according to the state of an illness and everyone for use to the sensitivity of antibiotics.
Using method: (this water preparation, unguentum need be used)
One, face and both hands are cleaned with cleansing milk.
Two, the branch of removing facial acne, the folliculitis thing that oozes, the skin ulcer face that the cotton balls scouring of soaking with medicinal agent was removed.
Three, select for use suitable smelting to treat the antibiotics unguentum of own facial acne, ointment is coated in facial skin ulcer face uniformly, suck skin permeation meat by steam, the reuse ultrasound waveguide is gone into medicine, make its medicine reach corium, help medicine and further absorb, give full play to the antiinflammatory action of medicine bactericidal action and hormone, make the very fast healing of skin facial acne, thereby reach ideal therapeutic effect.Serious facial acne treatment once has the significant effective fruit, can heal entirely through 6～8 treatment work, and the lighter treats and can heal entirely through 1～2 smelting.
Of the present inventionly further describe through embodiment again:
Embodiment: clinical treatment acne, folliculitis statistics.158 examples:
| Imitate forever | Case load | ????％ |
| Recovery from illness | ????156 | ????98.73％ |
| Produce effects | ????2 | ????1.27％ |
| Effectively total | ????158 | ????100％ |
Through clinical verification, quote the treatment of said medicine and method, facial acne, folliculitis are after one week, the original scraggly pimple of skin surface is eliminated substantially, and skin only stays purple point and point-like blood crusts, continues 2～3 weeks of treatment, purple point and blood crusts that skin surface stays disappear gradually, show the elasticity of normal skin, face skin is soft and moist, and cleaning is rich in gloss.
In the smelting treatment process to the produce effects example through relating: insomnia, dyspepsia are arranged, and symptoms such as menoxenia are divided in considering due to the imbalance of oozing.
Facts have proved, a large amount of antibiotics and hormone combination, it is effectively killing and suppressing propionibacterium acnes.Its curative effect is better than acne treatment medicine and cosmetics in the market.
Advantage of the present invention is that cost is low, easily grasps, have no side effect, and instant effect, preventing from scar, color spot made skin pure white, fine and smooth after smelting was treated, and flexible gloss.
Claims (4)
- One, a kind of water preparation, unguentum for the treatment of acne, folliculitis, eczema is characterized in that the composed as follows of this medicine:1, water preparation (weight 500ml)Chloramphenicol inj: 1～2gThree nitrogen are eaten nucleoside injection: 400～800mgHydrocortisone injection: 40～80mg2, unguentum (weight 80g)Antibiotics: 1.2～10gDexamethasone tablet: 10～20mgMetronidazole: 3～4g
- Two, water preparation according to claim 1 is characterized in that: get 75% ethanol 300ml, adding distil water 100ml is the clear, colorless water preparation together with said medicine mix homogeneously in measuring cup.
- Three, unguentum according to claim 2 is characterized in that: medicine is added mortar be ground into fine-powdered, mix well with the 50g medical ventolin and be unguentum.
- Four, unguentum according to claim 2 is characterized in that: described antibiotics is penicillin, cephalosporin, streptomycin, erythromycin, sulfanilamide.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 97111378 CN1202358A (en) | 1997-06-12 | 1997-06-12 | Medicinal liquid and ointment for curing ache folliculitis and eczema |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 97111378 CN1202358A (en) | 1997-06-12 | 1997-06-12 | Medicinal liquid and ointment for curing ache folliculitis and eczema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1202358A true CN1202358A (en) | 1998-12-23 |
Family
ID=5171749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 97111378 Pending CN1202358A (en) | 1997-06-12 | 1997-06-12 | Medicinal liquid and ointment for curing ache folliculitis and eczema |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1202358A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140271921A1 (en) * | 2002-08-26 | 2014-09-18 | Sla Pharma Ag | Pharmaceutical composition |
| CN105030805A (en) * | 2015-07-27 | 2015-11-11 | 张建明 | Acne-eliminating tincture medicine and preparation method thereof |
| CN105412104A (en) * | 2015-12-10 | 2016-03-23 | 韩俊峰 | Liquid medicine for treating acne and preparation method thereof |
| CN106492219A (en) * | 2016-11-30 | 2017-03-15 | 郑州仁宏医药科技有限公司 | A kind of Western medicine compound for treating skin eczema and its application |
-
1997
- 1997-06-12 CN CN 97111378 patent/CN1202358A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140271921A1 (en) * | 2002-08-26 | 2014-09-18 | Sla Pharma Ag | Pharmaceutical composition |
| US10709689B2 (en) * | 2002-08-26 | 2020-07-14 | Sla Pharma Ag | Pharmaceutical composition |
| CN105030805A (en) * | 2015-07-27 | 2015-11-11 | 张建明 | Acne-eliminating tincture medicine and preparation method thereof |
| CN105412104A (en) * | 2015-12-10 | 2016-03-23 | 韩俊峰 | Liquid medicine for treating acne and preparation method thereof |
| CN106492219A (en) * | 2016-11-30 | 2017-03-15 | 郑州仁宏医药科技有限公司 | A kind of Western medicine compound for treating skin eczema and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gaviria Morales et al. | Primary cutaneous cryptococcosis due to cryptococcus neoformans in an immunocompetent host treated with itraconazole and drainage: Case report and review of the literature | |
| CN1052891C (en) | Gargle for aphtha | |
| CN1202358A (en) | Medicinal liquid and ointment for curing ache folliculitis and eczema | |
| Shannon et al. | Low-frequency ultrasound debridement (Sonoca-185) in acute wound management: A case study | |
| CN101822827A (en) | Preparation for cosmetic dermatology and scar repairing | |
| CN115671209A (en) | Medicine and food dual purpose Chinese medicinal product for treating diabetic foot and its manufacturing method | |
| Liden et al. | Hypochlorous acid: Its multiple uses for wound care | |
| CN1911231A (en) | Medicine for treating burns | |
| Hollander et al. | Using an esterified hyaluronan fleece to promote healing in difficult-to-treat wounds | |
| CN110302228A (en) | A kind of biological agent that treating hemorrhoid and its application | |
| CN1127970C (en) | Ointment for treating burn and its preparing process | |
| CN1044778C (en) | Suppurative wound treating medicine for domestic animal | |
| Hendrickson | Principles of wound management and the use of drains | |
| DE69013139T2 (en) | Means for the prevention, diagnosis and therapy of rheumatic, autoimmune, skin and connective tissue diseases of unknown etiology and methods for their preparation and use. | |
| CN101897874B (en) | External healing Chinese medicinal ointment | |
| Forrest | The treatment of pressure sores | |
| RU2228763C1 (en) | Method for treating the cases of purulent wounds | |
| RU2414909C2 (en) | Medication "regenerin" for local treatment of purulent diseases of soft tissues and method of its obtaining | |
| Fothergill | A Clinical Lecture ON THE BAD HABIT OF VAGINAL DOUCHING: Given at the Manchester Royal Infirmary | |
| Thenmozhi et al. | Hyperbaric oxygen therapy: Therapeutic role in various cases–A case series | |
| RU2147435C1 (en) | Method for treating purulent wounds and burns | |
| Haesler | WHAM evidence summary: Sugar dressing for wound healing and treating wound infection in resource limited settings | |
| Sakata et al. | Necrotic wound caused by jararaca (Bothrops jararaca) in a dog-hyperbaric oxygen therapy (HBTO) | |
| Rabufettia et al. | Elizabeth Gaviria Moralesa Marco Guidib, c Tomas Peterkab, d | |
| AvtAR et al. | A Prospective Study to Evaluate the Effectiveness of Negative-pressure Wound Therapy for Management of Acute Traumatic and Chronic Wound in Orthopedics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |